+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Artificial Intelligence in Medicine Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 193 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337546
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Artificial intelligence is advancing the transformation of the healthcare sector, delivering new capabilities in patient care, diagnostics, and operational efficiency. As digital health platforms evolve, business leaders are looking to AI in medicine to drive improved outcomes, optimize workflows, and foster ecosystem-wide innovation.

Market Snapshot: Artificial Intelligence in Medicine Market

The Artificial Intelligence in Medicine Market is experiencing rapid expansion, with total market value projected to accelerate from USD 12.64 billion in 2024 to USD 15.62 billion in 2025, and anticipated to reach USD 75.33 billion by 2032. This growth reflects the industry’s ongoing investment in advanced machine learning, computer vision, natural language processing, and their integration into clinical workflows and hospital operations. AI in medicine continues to shape next-generation healthcare by offering data-driven solutions that serve as critical infrastructure for global health systems.

Scope & Segmentation of Artificial Intelligence in Medicine

  • Component: Services and software, combining consulting, integration and deployment, application software, and system software to support end-to-end implementation across care delivery networks.
  • Technology Type: Computer vision, machine learning, natural language processing, and robotics are core to automating clinical and administrative processes, improving accuracy and scaling advanced analytics.
  • Deployment Mode: Cloud-based and on-premise models address the security, customization, and infrastructure preferences of various healthcare organizations.
  • Application Areas: Diagnostics, including medical imaging and pathology detection, drug discovery, and treatment solutions are priority use cases, addressing critical gaps in efficiency and quality.
  • End-User: Healthcare providers (clinics, hospitals), pharmaceutical companies, research institutes, and academic centers are adopting AI tools to streamline operations, clinical trials, and knowledge transfer.
  • Disease Type: Supports areas such as cardiology, dermatology, gastroenterology, neurology, obstetrics and gynecology, oncology, ophthalmology, orthopedics, pediatrics, and urology, targeting disease-specific challenges with tailored algorithms.
  • Regional Coverage: The market spans the Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East & Africa (including major countries such as the United Kingdom, Germany, France, Russia, and others), and Asia-Pacific (notably China, India, Japan, Australia, and key Southeast Asian economies).
  • Company Coverage: Profiles include global leaders and innovators such as Aidoc Medical Ltd., Allscripts Healthcare Solutions, BenevolentAI Limited, Butterfly Network, CloudMedx, Enlitic, Epic Systems, Exscientia, Freenome Holdings, GE Healthcare, Google (Alphabet), HeartFlow, IBM, Insilico Medicine, Intel, Philips, Medtronic, NVIDIA, Owkin, PathAI, Qventus, Recursion Pharmaceuticals, Siemens Healthineers, Tempus Labs, Viz.ai, and Zebra Medical Vision.

Key Takeaways

  • Deep learning and data accessibility are enabling AI to deliver new insights in diagnostic imaging, supporting risk assessment and ongoing patient monitoring initiatives.
  • Natural language processing is increasingly deployed to reduce the administrative burden of clinical documentation while improving the reliability and standardization of health records.
  • AI-enabled robotics and algorithmic approaches are used to enhance the efficiency of surgical workflows, automate equipment management, and facilitate advanced therapeutic procedures.
  • Collaborative ventures between technology firms, research institutes, and healthcare providers are driving multidisciplinary development and supporting the validation of AI use cases in real-world clinical settings.
  • Regional differences in regulatory frameworks, reimbursement policies, and digital maturity are influencing how quickly organizations adopt AI-powered tools and shape the customization strategies of technology vendors.

Tariff Impact on the Medical AI Ecosystem

Recent U.S. tariffs applied to select medical AI components are encouraging reevaluation of procurement models and supply chain partnerships across healthcare technology sectors. Higher costs for critical semiconductor chips have led some vendors and providers to diversify sourcing or negotiate with alternative suppliers, while others pursue regional manufacturing capabilities to mitigate risk. These dynamics are encouraging greater focus on building flexible partnerships, supporting resilience and ongoing technology innovation amid external pressures.

Methodology & Data Sources

This analysis in the report utilizes a mixed-methods approach, combining direct interviews with healthcare executives, clinicians, and technology specialists. Comprehensive secondary research draws on regulatory analysis, peer-reviewed studies, case reviews, and patent analytics. All insights are validated via data triangulation and expert review to ensure actionable, reliable guidance.

Why This Report Matters

  • Delivers relevant intelligence for senior executives adapting to the convergence of artificial intelligence in medicine and digital health.
  • Provides a strategic view of procurement imperatives, integration pathways, and evolving partnership ecosystems for competitive advantage.
  • Enables benchmarking of vendors, monitors emerging trends, and supports informed, resilient planning for long-term market participation.

Conclusion

Senior leaders leveraging this report gain insight into the critical drivers, opportunities, and real-world challenges shaping the AI in medicine landscape. Informed decision-making supports organizational readiness and unlocks value in a rapidly evolving health ecosystem.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. AI-driven precision drug discovery pipelines transforming personalized therapy development
5.2. Integration of AI-powered telehealth platforms enhancing remote diagnostic accuracy
5.3. AI adoption accelerating across clinical and diagnostic applications
5.4. Leveraging deep learning algorithms for real-time analysis of histopathology images in cancer diagnostics
5.5. Deploying AI-enhanced remote patient monitoring systems for proactive chronic disease management
5.6. Integrating AI-driven predictive analytics into hospital resource management for optimized patient flow
5.7. Real-world evidence and predictive analytics gaining traction in AI-driven care
5.8. Adoption of AI algorithms in robotic surgery systems drives precision and reduces postoperative complications
5.9. Natural language processing platforms automate clinical documentation to reduce physician burnout and errors
5.10. AI-powered genomics platforms accelerate precision oncology by identifying novel therapeutic targets
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Artificial Intelligence in Medicine Market, by Component
8.1. Services
8.1.1. Consulting Services
8.1.2. Integration & Deployment Services
8.2. Software
8.2.1. Applications Software
8.2.2. System Software
9. Artificial Intelligence in Medicine Market, by Technology Type
9.1. Computer Vision
9.2. Machine Learning
9.3. Natural Language Processing
9.4. Robotics
10. Artificial Intelligence in Medicine Market, by Deployment Mode
10.1. Cloud-Based
10.2. On-Premise
11. Artificial Intelligence in Medicine Market, by Application Areas
11.1. Diagnostics
11.1.1. Medical Imaging
11.1.2. Pathology Detection
11.2. Drug Discovery
11.3. Treatment
12. Artificial Intelligence in Medicine Market, by End-User
12.1. Healthcare Providers
12.1.1. Clinics
12.1.2. Hospitals
12.2. Pharmaceutical Companies
12.3. Research Institutes & Academic Centers
13. Artificial Intelligence in Medicine Market, by Disease Type
13.1. Cardiology
13.2. Dermatology
13.3. Gastroenterology
13.4. Neurology
13.5. Obstetrics & Gynecology
13.6. Oncology
13.7. Ophthalmology
13.8. Orthopedics
13.9. Pediatrics
13.10. Urology
14. Artificial Intelligence in Medicine Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Artificial Intelligence in Medicine Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Artificial Intelligence in Medicine Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Aidoc Medical Ltd.
17.3.2. Allscripts Healthcare Solutions, Inc.
17.3.3. BenevolentAI Limited
17.3.4. Butterfly Network, Inc.
17.3.5. CloudMedx Inc.
17.3.6. Enlitic, Inc.
17.3.7. Epic Systems Corporation
17.3.8. Exscientia plc
17.3.9. Freenome Holdings, Inc.
17.3.10. GE Healthcare
17.3.11. Google LLC By Alphabet Inc.
17.3.12. HeartFlow, Inc.
17.3.13. IBM Corporation
17.3.14. Insilico Medicine, Inc.
17.3.15. Intel Corporation
17.3.16. Koninklijke Philips N.V.
17.3.17. Medtronic plc
17.3.18. NVIDIA Corporation
17.3.19. Owkin, Inc.
17.3.20. PathAI, Inc.
17.3.21. Qventus, Inc.
17.3.22. Recursion Pharmaceuticals, Inc.
17.3.23. Siemens Healthineers AG
17.3.24. Tempus Labs, Inc.
17.3.25. Viz.ai, Inc.
17.3.26. Zebra Medical Vision Ltd.
List of Tables
List of Figures

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Artificial Intelligence in Medicine market report include:
  • Aidoc Medical Ltd.
  • Allscripts Healthcare Solutions, Inc.
  • BenevolentAI Limited
  • Butterfly Network, Inc.
  • CloudMedx Inc.
  • Enlitic, Inc.
  • Epic Systems Corporation
  • Exscientia plc
  • Freenome Holdings, Inc.
  • GE Healthcare
  • Google LLC By Alphabet Inc.
  • HeartFlow, Inc.
  • IBM Corporation
  • Insilico Medicine, Inc.
  • Intel Corporation
  • Koninklijke Philips N.V.
  • Medtronic plc
  • NVIDIA Corporation
  • Owkin, Inc.
  • PathAI, Inc.
  • Qventus, Inc.
  • Recursion Pharmaceuticals, Inc.
  • Siemens Healthineers AG
  • Tempus Labs, Inc.
  • Viz.ai, Inc.
  • Zebra Medical Vision Ltd.

Table Information